Mometasone Furoate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

74 API Suppliers, 34 USDMF, 29 CEP/COS, 9 JDMF, 8 EU WC, 7 KDMF, 28 NDC API, 42 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

50 Drugs in Development

50 Drugs in Development

INTERMEDIATES

2 Intermediates Suppliers

2 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

310 FDF Dossiers, 40 FDA Orange Book, 131 Europe, 21 Canada, 59 Australia, 29 South Africa, 30 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

OINTMENT;TOPICAL - 0.1%, CREAM;TOPICAL - 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, LOTION;TOPICAL - 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, AEROSOL, METERED;INHALATION - 0.05MG/INH, AEROSOL, METERED;INHALATION - 0.10MG/INH, AEROSOL, METERED;INHALATION - 0.20MG/INH, SPRAY, METERED;NASAL - 0.05MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, POWDER;INHALATION - 0.11MG/INH, POWDER;INHALATION - 0.22MG/INH, AEROSOL, METERED;INHALATION - 0.005MG/INH;0.05MG/INH, AEROSOL, METERED;INHALATION - 0.005MG/INH;0.1MG/INH, AEROSOL, METERED;INHALATION - 0.005MG/INH;0.2MG/INH

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 1 SPI Pharma, 4 DKSH, 6 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 6 Actylis, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 4 BASF, 3 DFE Pharma, 2 Finar, 7 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 10 Kerry, 1 Kima Chemical, 6 Microlex e.U, 1 Nanjing Bold Chemical, 1 Pharmatrans-Sanaq, 1 Pluviaendo, 1 Prachin Chemical, 9 Roquette, 6 Seppic, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 8 Sigachi Industries, 1 The Dow Chemical Company, 1 Valens Pharmachem, 1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

21 Fillers, Diluents & Binders, 21 Solubilizers, 17 Thickeners and Stabilizers, 17 Direct Compression, 11 Parenteral, 10 Coating Systems & Additives, 10 Co-Processed Excipients, 10 Topical, 9 Film Formers & Plasticizers, 7 Granulation, 6 Disintegrants & Superdisintegrants, 5 Rheology Modifiers, 5 Emulsifying Agents, 5 Controlled & Modified Release, 3 Lubricants & Glidants, 3 Taste Masking, 2 Chewable & Orodispersible Aids, 2 Surfactant & Foaming Agents, 2 Coloring Agents, 1 API Stability Enhancers

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 49 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 110 Finished Drug Prices, 14 Annual Reports

MARKET PLACE

14 APIs, 4 FDF Dossiers

PATENTS & EXCLUSIVITIES

28 US Patents, 1 US Exclusivities, 17 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 1 USP, 1 Others

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 19543 / DOSAGE - OINTMENT;TOPICAL - 0.1%

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
mometasone furoate(UNII: 04201GDN4R) (mometasone - UNII:8HR4QJ6DW8)	mometasone furoate	1mg in 1

Inactive Ingredients

Ingredient Name	A-S Medication Solutions	Cosette Pharmaceuticals, Inc.	Glenmark Pharmaceuticals Inc., USA	Harris Pharmaceutical, Inc.	Impax Generics	Merck Sharp & Dohme Corp.	NuCare Pharmaceuticals,Inc.	REMEDYREPACK INC.	Torrent Pharmaceuticals Limited	REMEDYREPACK INC.
HEXYLENE GLYCOL(KEH0A3F75J)
PETROLATUM(4T6H12BN9U)
PHOSPHORIC ACID(E4GA8884NN)
PROPYLENE GLYCOL MONOPALMITOSTEARATE(F76354LMGR)
PROPYLENE GLYCOL MONOSTEARATE(MZM1I680W0)
PROPYLENE GLYCOL STEARATE(MZM1I680W0)
Stearyl Alcohol(2KR89I4H1Y)
Titanium Dioxide(15FIX9V2JP)
Water(059QF0KO0R)
WHITE WAX(7G1J5DA97F)

Drug Product Composition: Mometasone Furoate